## ADMET prediction using ML 

This post is a step-by-step implementation of my approach to calculating the ADME(T) properties and it is meant for sharing, studying, and critiquing by fellow researchers who are new and interested in this topic. Most of the research paper that is implemented can be found in **ref** directory. 

### **Physicochemical Properties:**

*   [x] **Molecular Weight**
*   [x] **Heavy Atoms**
*   [x] **Aromatic Heavy Atoms**
*   [x] **Fraction Csp3**
*   [x] **Rotatable Bonds**
*   [x] **H-Bond Acceptors**
*   [x] **H-Bond Donors**
*   [x] **Ring Count**
*   [x] **Aromatic Ring Count**
*   [x] **Molar Refractivity**
*   [x] **tPSA**
*   [x] **LogP**
*   [ ] **pKa**
*   [ ] **LogS**

---

### **Medicinal Chemistry:**

*   [x] [**Lipinski Violations**](https://en.wikipedia.org/wiki/Lipinski%27s_rule_of_five) 
*   [x] [**Ghose Violations**](https://github.com/santuchal/adme_predection/blob/master/ref/ghose1999.pdf)
*   [x] [**Veber Violations**](https://github.com/santuchal/adme_predection/blob/master/ref/veber2002.pdf)
*   [x] [**Muegge Violations**](https://github.com/santuchal/adme_predection/blob/master/ref/muegge2001.pdf)
*   [x] [**Egan Violations**](https://github.com/santuchal/adme_predection/blob/master/ref/egan2000.pdf)
*   [x] [**PAINS Alerts**](https://en.wikipedia.org/wiki/Pan-assay_interference_compounds)
*   [x] **BRENK Alerts**

---

### **Absorption:**

*   [ ] **Caco-2**
*   [ ] **HIA**
*   [ ] **Pgp-substrate**
*   [ ] **Pgp-inhibitor**
*   [ ] **Oral Bioavailability**

---

### **Distribution:**

*   [ ] **BBBP**
*   [ ] **PPB**

---

### **Metabolism:**

*   [ ] **CYP450 inhibitor/substrate**
*   [ ] **1A2**
*   [ ] **2C9**
*   [ ] **2C19**
*   [ ] **2D6**
*   [ ] **3A4**

---

### **Excretion:**

*   [ ] **Half Life**

---

### **Toxicity:**

*   **Macro Toxicity**
    *   [ ] **Rodent Acute Toxicity**
    *   [ ] **Human Acute Toxicity**
    *   [ ] **Carcinogenicity**
    *   [ ] **Ames Mutagenicity**
    *   [ ] **Hepatotoxicity**
*   **Micro Toxicity**
    *   [ ] **hERG inhibition**
    *   [ ] **AR**
    *   [ ] **ER**
    *   [ ] **Aromatase**
    *   [ ] **PPAR-Y**
    *   [ ] **AhR**
    *   [ ] **MMP**
    *   [ ] **p53**
    *   [ ] **ARE**
    *   [ ] **HSE**
    *   [ ] **ATAD5**

---